Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC STING agonist-3 | 2138299-29-1 | >98.0% | 750.8 g/mol | C37H42N12O6 | 5 MG
SDP

Catalog No. 5000245211
Encompass_Preferred

diABZI STING Agonist 3 is a selective, non-nucleotide small-molecule agonist of the STING pathway used in preclinical research to activate innate immune signaling and study antitumor immunostimulatory effects. It is employed in biochemical and cell-based assays to probe STING activation and downstream interferon responses.

  • Activates STING signaling in biochemical and cell-based assays.
  • Demonstrates potent binding affinity and cellular activity.
  • Suitable for in vitro and preclinical in vivo studies.
  • Available in small research pack sizes for assay development.
  • High purity appropriate for research applications.

Catalog No. 50-002-45211 Supplier Medchemexpress LLC Supplier No. HY1036655MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

diABZI STING Agonist 3 is a selective, non-nucleotide small-molecule agonist of the STING pathway used in preclinical research to activate innate immune signaling and study antitumor immunostimulatory effects. It is employed in biochemical and cell-based assays to probe STING activation and downstream interferon responses.

  • Activates STING signaling in biochemical and cell-based assays.
  • Demonstrates potent binding affinity and cellular activity.
  • Suitable for in vitro and preclinical in vivo studies.
  • Available in small research pack sizes for assay development.
  • High purity appropriate for research applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.